To further enhance the standardized diagnosis and treatment of psoriasis within the region, promote cross-institutional clinical experience and academic exchange, improve the precision of related disease management, and implement comprehensive chronic disease care, the Chengdu High-Tech Medical Association successfully convened the "Innovative Exchange Conference on Standardized Psoriasis Diagnosis and Treatment" in Chengdu on February 7, 2026.  Organized by the Chengdu High-Tech Medical Association, this conference focused on the core clinical challenges of psoriasis, addressing key topics such as early diagnosis and precise intervention, comparative clinical efficacy of IL-17A inhibitors, and standardized management of the entire psoriasis disease course. It featured diverse sessions including thematic presentations, scenario simulations, and expert discussions, bringing together multidisciplinary professionals to jointly explore optimized pathways and practical solutions for psoriasis diagnosis and treatment.  Centered on patients, guided by academic principles, and committed to collaboration, the conference aimed to establish a high-level cross-institutional academic exchange platform. It sought to synchronize the advancement of psoriasis diagnosis and treatment concepts and techniques within the region, provide clinicians with practical and cutting-edge diagnostic approaches, and ultimately help patients receive more precise, long-term, and high-quality care, achieving scientific management throughout the disease lifecycle.